borteshil 2mg injection - Bortezomib (2mg) medicine

Bortenat 2mg Injection: Comprehensive Medicine Guide

No reviews yet
🏭 Shilpa Medicare Ltd 📦 Varies by brand 💊 Allopathy 📅 Updated: Oct 18, 2026
⚠️ Hepatotoxicity Risk 📋 Prescription Required 💊 Generic Available
Medically Reviewed
11 min read
Evidence: High
Reviewed by
SaathiMed Expert Panel | Oct 18, 2026
🩺
Medically Fact-Checked & Clinically Verified by SaathiMed Clinical Review Board
Clinical Reference Standards: CDSCO (Central Drugs Standard Control Organisation), Indian Pharmacopoeia (IP) & WHO | Last Updated: September 2026

When to Call Your Doctor IMMEDIATELY

  • Severe numbness, tingling, or weakness in hands or feet
  • Unusual bleeding or bruising, blood in stool or urine
  • Fever, chills, or sore throat
  • Shortness of breath, chest pain, or swelling in legs
  • Seizures, severe headache, confusion, or vision changes
  • Decreased urine output or swelling in feet
  • Severe abdominal pain or vomiting

If experiencing severe symptoms, call emergency services immediately.

What is borteshil 2mg injection used for?

This medicine is a prescription injection containing bortezomib 2 mg, used to treat multiple myeloma and mantle cell lymphoma. It works by inhibiting the proteasome, leading to cancer cell death. It is given by a healthcare professional and requires regular monitoring.

  • Generic Name: Bortezomib (2mg)
  • Manufacturer: Shilpa Medicare Ltd
  • Form: Allopathy
  • Pregnancy Category: Consult doctor
  • Prescription Required: Yes

🇮🇳 borteshil 2mg injection के बारे में (Hindi Summary)

उपयोग: यह दवा बोर्टेज़ोमिब 2 मिलीग्राम इंजेक्शन के रूप में एक प्रिस्क्रिप्शन दवा है, जिसका उपयोग मल्टीपल मायलोमा और मेंटल सेल लिंफोमा के इलाज के लिए किया जाता है। यह प्रोटियासोम इनहिबिटर वर्ग की दवा है, जो कैंसर कोशिकाओं को मारने में मदद करती है। यह दवा डॉक्टर या नर्स द्वारा इंजेक्शन के माध्यम से दी जाती है, इसे घर पर स्वयं नहीं लगाया जा सकता। इस दवा का उपयोग वयस्कों में किया जाता है, अक्सर अन्य कैंसर रोधी दवाओं के साथ। इस दवा के गंभीर दुष्प्रभाव हो सकते हैं, इसलिए इसका उपयोग ऑन्कोलॉजिस्ट की देखरेख में ही किया जाना चाहिए।

साइड इफेक्ट्स: आम दुष्प्रभावों में थकान, मतली, दस्त, कब्ज, उल्टी, भूख न लगना, बुखार, सिरदर्द, अनिद्रा और हाथ-पैरों में झुनझुनी या सुन्नपन शामिल हैं। गंभीर दुष्प्रभावों में गंभीर न्यूरोपैथी, कम प्लेटलेट काउंट, कम श्वेत रक्त कोशिका काउंट, कम लाल रक्त कोशिका काउंट, निम्न रक्तचाप, हृदय की समस्याएं, फेफड़ों की समस्याएं, यकृत की समस्याएं और मस्तिष्क की एक गंभीर स्थिति शामिल हैं। दुर्लभ दुष्प्रभावों में गंभीर एलर्जी प्रतिक्रियाएं, ट्यूमर लिसिस सिंड्रोम और रक्त के थक्के शामिल हैं।

सुरक्षा सलाह: यह दवा केवल योग्य स्वास्थ्य पेशेवर द्वारा अस्पताल या क्लिनिक में ही दी जानी चाहिए। स्वयं इंजेक्शन न लगाएं। अपने डॉक्टर को अपनी सभी चिकित्सीय स्थितियों के बारे में बताएं, विशेष रूप से यकृत रोग, गुर्दा रोग, हृदय रोग, मधुमेह या तंत्रिका समस्याएं। यदि आप गर्भवती हैं, गर्भवती होने की योजना बना रही हैं या स्तनपान करा रही हैं तो अपने डॉक्टर को बताएं। उपचार के दौरान और उसके कुछ समय बाद तक प्रभावी गर्भनिरोधक का उपयोग करें। संक्रमण वाले लोगों के निकट संपर्क से बचें। संक्रमण के किसी भी लक्षण, असामान्य रक्तस्राव या चोट, हाथ-पैरों में सुन्नपन या झुनझुनी, चक्कर आना, बेहोशी या सांस लेने में कठिनाई की तुरंत रिपोर्ट करें।

💡 Did You Know? Over 80% of the antiretroviral drugs used globally to combat AIDS are supplied by Indian pharmaceutical companies.

💊 borteshil 2mg injection Uses & Benefits

  • [{"condition":"Multiple myeloma","description":"This medicine is used to treat multiple myeloma, a cancer of plasma cells, in adults.
  • It is often given in combination with other medicines such as dexamethasone, lenalidomide, or melphalan.","evidence":"Well-established"},{"condition":"Mantle cell lymphoma","description":"This medicine is used to treat mantle cell lymphoma, a type of non-Hodgkin lymphoma, in adults who have received at least one prior therapy.","evidence":"Well-established"}]

Off-label uses: [{"condition":"Waldenström macroglobulinemia","description":"Sometimes used off-label in patients with Waldenström macroglobulinemia, a rare type of lymphoma.","evidence":"Limited"},{"condition":"AL amyloidosis","description":"Sometimes used off-label in patients with AL amyloidosis, a rare disease where abnormal proteins build up in organs.","evidence":"Limited"}]

Primary treatment for: Multiple myeloma

Also treats: Mantle cell lymphoma

📋 Drug Information

Generic Name(s)Bortezomib (2mg)
Brand Nameborteshil 2mg injection
ManufacturerShilpa Medicare Ltd
Packaging / FormVaries by brand (Allopathy)
Therapeutic ClassANTI NEOPLASTICS
Action ClassProteasome inhibitor
Route of AdministrationParenteral (intravenous or subcutaneous)
StorageStore unopened vials in a refrigerator at 2°C to 8°C (36°F to 46°F). Protect from light. Do not freeze. Once reconstituted, the solution should be used immediately or stored as per the manufacturer's instructions. Keep out of reach of children.
Shelf LifeThe shelf life of the unopened vial is typically 24 months from the date of manufacture. Refer to the product label for the exact expiry date.
WHO GuidelineBortezomib is included in the WHO Model List of Essential Medicines for the treatment of multiple myeloma.
ICMR GuidelineNot established from the available information.

👨‍⚕️ Doctor's Practical Tips

Evidence-based practical advice from experienced clinicians

1
Administer this medicine under the supervision of an oncologist experienced in cancer chemotherapy.
2
Monitor complete blood counts before each dose and adjust dose for thrombocytopenia or neutropenia.
3
Assess patients for symptoms of peripheral neuropathy at each visit; dose reduction may be needed.
4
Monitor blood pressure regularly; advise patients to maintain adequate hydration.
5
Use effective contraception in women of childbearing potential during treatment.
6
Consider antiviral prophylaxis for herpes zoster reactivation.
7
Monitor liver and kidney function tests regularly.
8
Educate patients about the signs of tumor lysis syndrome and when to seek help.

🔍 Is This Medicine Right for Your Symptom?

Educational reference. Always consult a doctor for diagnosis.

✅
Multiple myeloma
This medicine is commonly prescribed for this condition.
Likely Use
✅
Mantle cell lymphoma
This medicine is approved for this condition.
Likely Use
❌
Fever
This medicine is not a primary fever reducer.
Not Primary

🔬 How This Medicine Works (Pharmacology)

Pharmacokinetics

AbsorptionThis medicine is administered intravenously or subcutaneously. After subcutaneous administration, peak plasma concentrations are reached in about 0.5 to 1 hour. The absolute bioavailability after subcutaneous administration is approximately 60% compared to intravenous administration.
DistributionThis medicine has a large volume of distribution, approximately 500 to 1000 L in adults. It distributes into body tissues, including the bone marrow and tumor cells. It does not significantly bind to red blood cells.
Protein BindingThis medicine is approximately 83% bound to plasma proteins.
MetabolismThis medicine is primarily metabolized in the liver by cytochrome P450 enzymes, mainly CYP3A4, CYP2C19, and CYP1A2. It is also metabolized by other enzymes. The metabolites are inactive.
Half-LifeThe elimination half-life of this medicine is approximately 9 to 15 hours after intravenous administration, and 40 to 60 hours after subcutaneous administration due to slower absorption.
ExcretionThis medicine and its metabolites are excreted primarily in the urine (approximately 60-80%) and to a lesser extent in the feces. Renal excretion is not a major route for unchanged drug.
BioavailabilityThe absolute bioavailability after subcutaneous administration is approximately 60%. After intravenous administration, bioavailability is 100%.
Onset of ActionThe onset of action is not immediate. It takes several days to weeks for the therapeutic effects to become apparent, as it requires time to induce apoptosis in cancer cells.
Peak Plasma TimeAfter subcutaneous administration, peak plasma concentrations are reached in about 0.5 to 1 hour. After intravenous administration, peak concentrations are reached at the end of infusion.
Duration of ActionThe duration of action is not well defined, but the effects on proteasome inhibition last for at least 24 hours after a dose. The clinical effects are cumulative over the treatment course.

How It Works

This medicine is a proteasome inhibitor. It reversibly inhibits the chymotrypsin-like activity of the 26S proteasome, a large protein complex that degrades ubiquitinated proteins. By blocking the proteasome, this medicine prevents the breakdown of proteins that regulate the cell cycle and apoptosis, such as IκB, p53, and Bax. This leads to cell cycle arrest and apoptosis of cancer cells, particularly multiple myeloma cells. It also inhibits NF-κB activation, which is important for cancer cell survival and growth.

Mechanism Steps

1
Binding to proteasome: This medicine binds reversibly to the catalytic site of the 26S proteasome, specifically inhibiting its chymotrypsin-like activity.
2
Accumulation of proteins: Inhibition of the proteasome leads to accumulation of ubiquitinated proteins, including those that regulate cell cycle and apoptosis.
3
Cell cycle arrest: The accumulation of proteins such as p53 and p21 causes cell cycle arrest at the G2-M phase.
4
Apoptosis: The cellular stress triggers apoptosis through the intrinsic pathway, involving Bax and caspase activation.
5
Inhibition of NF-κB: This medicine prevents the degradation of IκB, thereby inhibiting NF-κB activation, which is important for cancer cell survival and drug resistance.

💡 How to Take borteshil 2mg injection

Strength: This medicine is available as a lyophilized powder for injection in a single-use vial containing 2 mg of bortezomib. After reconstitution, the concentration is 1 mg/mL.

1This medicine is given by a healthcare professional as an intravenous or subcutaneous injection.
2You do not need to do anything to prepare for the injection except follow your doctor's instructions.
3For intravenous administration, the reconstituted solution is given as a bolus over 3-5 seconds.
4For subcutaneous administration, the solution is injected under the skin, usually in the thigh or abdomen.
5After the injection, you will be monitored for any immediate reactions.
6Drink plenty of fluids before and after the injection to stay hydrated.
7Report any side effects to your doctor immediately.

Dosage Information

Adult DosageThe recommended dose of this medicine for multiple myeloma and mantle cell lymphoma is 1.3 mg/m² body surface area administered as an intravenous or subcutaneous injection. The dosing schedule varies by indication and combination regimen. For example, in multiple myeloma, it may be given on days 1, 4, 8, and 11 of a 21-day cycle. Dose must be individualized by a qualified clinician based on indication, age, weight, renal and hepatic function, and response to treatment. Dose reductions may be required for toxicities such as peripheral neuropathy, thrombocytopenia, or neutropenia.
Pediatric DosagePediatric dosing is not established from available information. Consult a pediatric oncologist.
Elderly DosageNo specific dose adjustment is recommended for elderly patients based on age alone. However, elderly patients may be more susceptible to side effects such as peripheral neuropathy, fatigue, and cardiac toxicity. Monitor closely and adjust dose as needed based on tolerability.
Renal ImpairmentNo dose adjustment is required for patients with mild to moderate renal impairment (creatinine clearance ≥ 30 mL/min). Patients with severe renal impairment (creatinine clearance < 30 mL/min) should be monitored closely; dose reduction may be considered. This medicine is not removed by dialysis.
Hepatic ImpairmentPatients with mild hepatic impairment (bilirubin ≤ 1× ULN and AST > ULN, or bilirubin > 1× to 1.5× ULN) do not require dose adjustment. Patients with moderate or severe hepatic impairment (bilirubin > 1.5× ULN) should be started at a reduced dose of 0.7 mg/m² in the first cycle, and subsequent doses may be escalated to 1.0 mg/m² or further reduced based on tolerability.
Maximum Daily DoseThe maximum recommended dose is 1.3 mg/m² body surface area per dose. The maximum cumulative dose per cycle depends on the schedule. Do not exceed the prescribed dose.

Dosage Timeline

🌅 Morning ❌ ☀️ Afternoon ❌ 🌆 Evening ❌ 🌙 Night ❌

🍽️ Food Timing Guide

Grapefruit
Avoid
May increase bortezomib levels and toxicity.
St. John's wort
Avoid
May decrease bortezomib efficacy.
Alcohol
Avoid
May increase liver toxicity and side effects.

⏰ What to Do If You Miss a Dose

📌 You miss an appointment for your injection
→ Contact your doctor or clinic as soon as possible to reschedule.
💡 Do not attempt to self-administer a double dose.
📌 You are unable to attend due to travel
→ Inform your doctor in advance to adjust the schedule.
💡 Do not skip doses without medical advice.

⚠️ Side Effects of borteshil 2mg injection

✅ Common Side Effects

Fatigue (Very common (>10%))
Rest when needed. If severe or persistent, consult your doctor.
Nausea (Very common (>10%))
Take anti-nausea medicines as prescribed. Eat small, frequent meals.
Diarrhea (Very common (>10%))
Stay hydrated. Avoid spicy foods. If severe, consult your doctor.
Constipation (Very common (>10%))
Increase fiber and fluid intake. Use stool softeners if recommended.
Peripheral neuropathy (Common (1-10%))
Report tingling, numbness, or pain in hands or feet to your doctor immediately.
Thrombocytopenia (Very common (>10%))
Regular blood tests are needed. Report unusual bleeding or bruising.
Fever (Common (1-10%))
Use acetaminophen if approved by your doctor. Report persistent fever.
Headache (Common (1-10%))
Rest and stay hydrated. Consult doctor if severe.

🚨 Serious Side Effects

Severe peripheral neuropathy (Uncommon (0.1-1%))
Seek immediate medical attention if you experience severe pain, weakness, or inability to walk.
Severe thrombocytopenia (Common (1-10%))
Seek immediate medical attention if you notice bleeding gums, nosebleeds, or blood in urine or stool.
Neutropenia (Common (1-10%))
Seek immediate medical attention if you develop fever, chills, or sore throat.
Posterior reversible encephalopathy syndrome (PRES) (Rare (<0.1%))
Seek immediate medical attention if you have seizures, severe headache, confusion, or vision changes.
Heart failure (Uncommon (0.1-1%))
Seek immediate medical attention if you experience shortness of breath, swelling in legs, or chest pain.
Acute respiratory distress syndrome (ARDS) (Rare (<0.1%))
Seek immediate medical attention if you have difficulty breathing or low oxygen levels.

⚠️ Rare Side Effects

Tumor lysis syndrome
Seek immediate medical attention if you have nausea, vomiting, decreased urine output, or muscle cramps.
Severe allergic reactions (anaphylaxis)
Seek emergency help if you have rash, swelling, difficulty breathing, or dizziness.
Blood clots (deep vein thrombosis, pulmonary embolism)
Seek immediate medical attention if you have leg pain, swelling, or sudden shortness of breath.

Consult your doctor if you experience any unusual symptoms.

🔬 Drug Interactions

Drug Severity Effect
Ketoconazole Major
Rifampin Major
Warfarin Moderate
Aminoglycosides Moderate
Live vaccines Major
Antihypertensives Moderate
Grapefruit juice Moderate
St. John's wort Moderate
Alcohol Moderate
Diuretics Minor

🚨 Major Interactions

  • CYP3A4 inhibitors (e.g., ketoconazole, ritonavir)
  • CYP3A4 inducers (e.g., rifampin, carbamazepine)
  • Live vaccines

⚡ Moderate Interactions

  • Antihypertensives
  • Nephrotoxic drugs (e.g., aminoglycosides, amphotericin B)
  • Anticoagulants (e.g., warfarin)

🍷 Alcohol Interaction

Alcohol may increase the risk of liver toxicity and worsen side effects such as dizziness, drowsiness, and low blood pressure. It is advisable to avoid alcohol while receiving this medicine.

🔎 Check Your Other Medicines

Educational tool. Always confirm with your doctor or pharmacist.

🛡️ Safety & Warnings

🚫 Contraindications

["Hypersensitivity to bortezomib, boron, or mannitol","Severe thrombocytopenia (platelet count < 25,000/µL)","Severe neutropenia (ANC < 500/µL)","Severe hepatic impairment","Grade 2 or higher peripheral neuropathy","Concurrent live vaccine administration"]

⚠️ Warnings & Precautions

["This medicine should be administered under the supervision of a qualified oncologist.","Peripheral neuropathy is a common and potentially severe side effect. Dose reduction or discontinuation may be necessary.","Thrombocytopenia and neutropenia are common. Monitor blood counts closely.","Hypotension may occur. Monitor blood pressure and advise patients to avoid dehydration.","Heart failure and arrhythmias have been reported. Monitor cardiac function.","Posterior reversible encephalopathy syndrome (PRES) has been reported. Discontinue if suspected.","Tumor lysis syndrome may occur. Ensure adequate hydration and monitor electrolytes.","Hepatotoxicity can occur. Monitor liver enzymes.","Embryo-fetal toxicity: Use effective contraception during treatment.","Avoid live vaccines during treatment."]

🤱 Lactation Safety

It is not known whether this medicine is excreted in human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

💊 Overdose Management

There is no known specific antidote for overdose with this medicine. In case of overdose, discontinue the medicine and provide supportive care. Monitor vital signs, blood counts, and liver and kidney function. Symptomatic treatment should be given as needed. Dialysis is not expected to be effective due to high protein binding.

⏰ Missed Dose

This medicine is administered by a healthcare professional. If you miss an appointment for your dose, contact your doctor or clinic as soon as possible to reschedule. Do not attempt to self-administer a double dose.

Additional Safety Advice

General Safety

This medicine must only be given by a qualified healthcare professional in a hospital or clinic setting. Do not attempt to self-administer. Inform your doctor about all your medical conditions, especially liver disease, kidney disease, heart disease, diabetes, or nerve problems. Tell your doctor if you are pregnant, planning to become pregnant, or breastfeeding. Use effective contraception during treatment and for some time after. Avoid close contact with people who have infections. Report any signs of infection, unusual bleeding or bruising, numbness or tingling in hands or feet, dizziness, fainting, or difficulty breathing immediately. Do not drive or operate heavy machinery if you feel dizzy or weak. Drink plenty of fluids to stay hydrated. Your doctor will do regular blood tests to check your blood counts, liver and kidney function.

👴 Special Considerations for Elderly

💡 For Patients Above 65

Elderly patients may be more susceptible to side effects such as peripheral neuropathy, fatigue, and cardiac toxicity. Close monitoring and dose adjustments may be necessary. No specific dose adjustment based on age alone is recommended.

🤰 Pregnancy Planning (TTC)

This medicine can cause fetal harm. Women of childbearing potential should use effective contraception during treatment and for at least 6 months after the last dose. Men with female partners of childbearing potential should also use effective contraception. If you are planning to become pregnant, consult your doctor before starting treatment.

🏥 Post-Surgery Considerations

This medicine may increase the risk of bleeding and infection after surgery. Inform your surgeon that you are receiving this medicine. Your doctor may recommend temporarily stopping the medicine before surgery. Follow your doctor's instructions regarding when to resume treatment.

🦷 Dental Procedures

This medicine can cause low platelet counts, which may increase the risk of bleeding during dental procedures. Inform your dentist that you are receiving this medicine. Your dentist may recommend postponing elective dental work until your blood counts recover. Good oral hygiene is important to prevent infections.

💚 Lifestyle Tips for Better Results

🏃
Maintain a healthy diet rich in fruits, vegetables, and lean proteins.
🥗
Stay hydrated by drinking plenty of fluids.
😴
Get adequate rest and sleep.
💧
Avoid alcohol and smoking.
🧘
Practice good hand hygiene to prevent infections.
🌞
Engage in light exercise as tolerated, but avoid activities that may cause injury.
🚭
Report any new symptoms to your doctor promptly.

🏋️ Exercise Considerations

Exercise should be tailored to your energy levels and overall condition. Avoid strenuous activities that may increase the risk of bleeding or injury, especially if you have low platelet counts. Gentle walking and stretching may be beneficial. Consult your doctor before starting any exercise program.

🥗 Diet Recommendations

Eat small, frequent meals to manage nausea.
Include protein-rich foods to support recovery.
Avoid grapefruit and grapefruit juice.
Avoid St. John's wort.
Limit alcohol consumption.
Stay well hydrated.

💼 Impact on Daily Work & Life

This medicine may cause fatigue, dizziness, and peripheral neuropathy, which can affect your ability to work or drive. Avoid driving or operating heavy machinery if you feel dizzy or weak. Discuss with your employer about flexible work arrangements during treatment.

🛑 When to Stop This Medicine

Do not stop this medicine without consulting your doctor. Your doctor may decide to stop treatment based on your response, side effects, or disease progression. If you experience severe side effects, contact your doctor immediately; they may adjust the dose or discontinue the medicine.

📅 Long-Term Use Effects

Long-term use of this medicine may lead to persistent peripheral neuropathy, which can be dose-limiting. Regular monitoring of blood counts, liver and kidney function, and neurological status is required. Some patients may experience cardiac toxicity. The risk of secondary cancers may be increased. Long-term effects on fertility are not fully known. Discuss with your doctor about monitoring and management of long-term effects.

🌿 Non-Medicine Approaches

These can complement medicine but do not replace prescribed treatment.

Carfilzomib

Another proteasome inhibitor used for multiple myeloma.

Evidence: Well-established
Ixazomib

An oral proteasome inhibitor used for multiple myeloma.

Evidence: Well-established
Stem cell transplant

May be considered for eligible patients with multiple myeloma.

Evidence: Well-established

💉 Vaccination Considerations

💉 If You're Getting Vaccinated

Live vaccines should not be administered during treatment with this medicine due to the risk of vaccine-associated infection. Inactivated vaccines may be given, but their effectiveness may be reduced. Consult your doctor before receiving any vaccine.

📦 Storage Guide

✅ DO

Store unopened vials in the refrigerator at 2°C to 8°C.

❌ DON'T

Do not freeze the vials.

✅ DO

Protect from light.

❌ DON'T

Do not store at room temperature for extended periods.

✅ DO

Keep out of reach of children.

❌ DON'T

Do not use if the solution is discolored or contains particles.

✈️ Traveling with This Medicine

This medicine is administered in a healthcare setting, so travel planning should be coordinated with your treatment schedule. If you need to travel, carry your prescription and medical records. The medicine should be stored in a refrigerator at 2°C to 8°C; if traveling, use a cooler with ice packs and ensure it does not freeze. Inform airport security about your medical condition and carry a doctor&#039;s letter. Plan your travel around your treatment cycles to avoid missing doses.

💰 Cost Analysis & Savings

👥 Real Patient Stories

Educational, anonymized scenarios. Individual results may vary.

👤 A 62-year-old man with multiple myeloma
He was started on this medicine along with dexamethasone. After the first cycle, his myeloma protein levels decreased significantly. He experienced mild fatigue and nausea, which were managed with supportive care. He emphasized the importance of regular blood tests and reporting side effects to his doctor.
💡 Lesson: Adherence to the treatment schedule and regular monitoring are key to managing multiple myeloma effectively.
👤 A 55-year-old woman with mantle cell lymphoma
She received this medicine as part of her treatment regimen. She developed peripheral neuropathy after the second cycle, which was managed by dose reduction. She learned to report symptoms early, which helped her doctor adjust the dose and prevent worsening of neuropathy.
💡 Lesson: Early reporting of side effects like peripheral neuropathy allows for timely dose adjustments and better tolerability.

💬 Questions Patients Often Ask

Q: How long does it take to work?

A: The effects of this medicine may take several weeks to become noticeable. Your doctor will monitor your response through regular tests.

Q: Can I take this medicine at home?

A: No, this medicine must be administered by a healthcare professional in a clinic or hospital setting.

Q: What should I do if I miss a dose?

A: Contact your doctor or clinic to reschedule your appointment. Do not attempt to self-administer a double dose.

Q: Is it safe during pregnancy?

A: This medicine can cause fetal harm. Use effective contraception during treatment and inform your doctor if you are pregnant or planning to become pregnant.

🤔 Common Patient Concerns

💭 These are the concerns patients most commonly raise

  • Can I take this medicine long-term?
  • Will it affect my kidney function?
  • Can I drive after taking this medicine?
  • Does it interact with my blood pressure medicine?
  • What if I miss a dose?
  • Can I drink alcohol while taking this?

🔄 Substitutes for borteshil 2mg injection

View All

Alternative brands with exact same active ingredient:

Medical Note: Always consult your doctor before switching medications.

🛑 Myths vs. Facts

  • Myth: Bortenat 2mg injection can be self-administered at home.
    Fact: This medicine must be given by a healthcare professional in a clinic or hospital setting.
  • Myth: Bortenat 2mg injection is a painkiller.
    Fact: This medicine is a chemotherapy agent used to treat certain cancers, not a painkiller.
  • Myth: Bortenat 2mg injection has no serious side effects.
    Fact: This medicine can cause serious side effects such as peripheral neuropathy, low blood counts, and heart problems.

🔄 Alternative Options

Generic Alternatives

  • Bortezomib

Brand Alternatives

  • Velcade
  • Bortenat

📊 Comparison with Similar Medicines

[{"medicine":"Bortezomib","class":"Proteasome inhibitor","route":"IV/SC","common_use":"Multiple myeloma, mantle cell lymphoma"},{"medicine":"Carfilzomib","class":"Proteasome inhibitor","route":"IV","common_use":"Multiple myeloma"},{"medicine":"Ixazomib","class":"Proteasome inhibitor","route":"Oral","common_use":"Multiple myeloma"}]

😊 Was this information helpful?

Browse Medicines A-Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Back to Medicines Directory